CHRS vs GME · rev $26.6M vs P/E 16, rev $3.63B
Coherus BioSciences Inc (CHRS) versus GameStop Corp. (GME) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
GameStop Corp. (GME) is a specialty retail company listed on US. It is led by Ryan Cohen.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported GME revenue for 2026-01-31 was $3.63B. Net income was $418.4M. Revenue was down 5.1% from 2025-02-01 to 2026-01-31. GME currently screens at market cap $9.78B and trailing P/E 16.3.
CHRS currently screens at market cap $223.7M. GME currently screens at market cap $9.78B and trailing P/E 16.3.
Not investment advice. Open the CHRS and GME stock pages for the full models.
Not investment advice.